+ Studies in 2000-2009 List
* Studies in Pre-2000 List

SEBACEOUS GLANDS + (Produce Skin Oils)
SINUSITIS (See 2000-2009 List)
SMALLPOX + (See Also COW POX [not good news])
SPINOCEREBELLAR ATAXIA/SCA (Inherited Neurodegenerative Disorder. See Also ATAXIA)

Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full-2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Drug Harms in the UK (full-2010) http://www.scribd.com/doc/41349905/Alcohol-Lancet-2010
Harms associated with psychoactive substances: findings of the UK National Drug Survey (abst-2010) http://jop.sagepub.com/cgi/content/abstract/24/2/147?rss=1
Alcohol ‘Most Harmful Drug’, According to Multicriteria Analysis (news-2010) http://www.sciencedaily.com/releases/2010/11/101101162138.htm
A summary of the health harms of drugs – Section 5 Cannabis (full-2011) http://www.nta.nhs.uk/uploads/healthharmsfinal-v1.pdf
Annual Causes of Death in the United States (article-2011) http://drugwarfacts.org/cms/?q=node/30
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/22129319/abstract/Safety_and_Side_Effects_of_Cannabidiol_a_Cannabis_sativa_Constituent_
Oregon’s workplaces safest ever, despite 40,000 medical marijuana patients (news-2011) http://www.examiner.com/article/oregon-s-workplaces-safest-ever-despite-40-000-medical-marijuana-patients
Is Pot Good For You? (news-2011) http://www.maps.org/media/view/is_pot_good_for_you/
Prescribing Cannabis for Harm Reduction (full-2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf
Medical Marijuana: Clearing Away the Smoke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716148
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Synthetic cannabinoid and marijuana exposures reported to poison centers (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22859662
Study on Non-Psychotropic Cannabinoid Proves to be Safe in Humans (news-2012) http://www.opposingviews.com/i/society/drug-law/study-non-psychotropic-cannabinoid-proven-be-safe-humans
Is Medical Marijuana Safe for Children? (news-2012) http://healthland.time.com/2012/11/28/is-medical-marijuana-safe-for-children/
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
The pharmacologic and clinical effects of medical cannabis (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State (abst + 1st page-2013) http://archpedi.jamanetwork.com/article.aspx?articleid=1691419&resultClick=3
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Physical harm due to chronic substance use. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23542091
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity? (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24084047
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24160757
Medical marijuana users don’t have protections from sub-par pot (news-2013) http://www.katu.com/news/investigators/Medical-marijuana-users-dont-have-protections-from-sub-par-pot-200499471.html
Is Medical Marijuana Safe For Children and Adolescents? (news-2013) http://www.wakingtimes.com/2013/05/27/is-medical-marijuana-safe-for-children-and-adolescents/
No detectable association between frequency of marijuana use and health or healthcare utilization (news-2013) http://www.eurekalert.org/pub_releases/2013-09/bumc-nda092313.php
Marijuana has no adverse effects on health, BU study suggests (news-2013) http://dailyfreepress.com/2013/09/25/marijuana-has-no-adverse-effects-on-health-bu-study-suggests/
Study: Recreational Marijuana Users Show No ‘Negative Health Outcomes’ (news-2013) http://www.leafscience.com/2013/09/24/study-recreational-marijuana-users-show-negative-health-outcomes/
No detectable association between frequency of marijuana use and health or healthcare utilization (news-2013) http://medicalxpress.com/news/2013-09-association-frequency-marijuana-health-healthcare.html
Alcohol or Cannabis? No Question Which Substance Poses a Greater Risk to Health (news-2013) http://www.huffingtonpost.com/paul-armentano/alcohol-or-cannabis_b_3799972.html
How Much Marijuana Does It Take For Someone To Overdose? (news-2013) http://www.theweedblog.com/how-much-marijuana-does-it-take-for-someone-to-overdose/
Phytocannabinoids and epilepsy (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full-2014) http://www.cfp.ca/content/60/12/1083.long
A new method of cannabis ingestion: The dangers of dabs? (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24930049
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst-2014)
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25035121
Re-branding cannabis: the next generation of chronic pain medicine? (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
Scientists Explain Why Marijuana Users Never Overdose (news-2014) http://www.leafscience.com/2014/01/08/scientists-explain-marijuana-users-never-overdose/
Which is more dangerous: marijuana or alcohol? (news-2014) http://www.abc15.com/dpp/news/local_news/water_cooler/which-is-more-dangerous-marijuana-or-alcohol Poll: 47% in under-40 crowd say booze worse than weed (news-2014) http://www.kirotv.com/news/news/rare-under-40-poll-whats-worse-marijuana-or-alcoho/nhP3y/
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25634572
The cannabis conundrum: Thinking outside the THC box (full-2015) http://onlinelibrary.wiley.com/doi/10.1002/jcph.511/full
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic
Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/nl9g6x6
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product—Colorado, March 2014 (full-2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article-2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter-2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample (abst-2015)
Change in perceived risk associated with marijuana use in the United States from 2002 to 2012 (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25646638
Responsible and controlled use: Older cannabis users and harm reduction (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25911027
A safer alternative: Cannabis substitution as harm reduction (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
European rating of drug harms (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25922421
Marijuana’s Risky Reputation Is Wafting Away (news-2015) http://www.livescience.com/50003-marijuana-risk-perception.html
Why Is Marijuana A Schedule I Drug? (news-2015) http://www.ibtimes.com/why-marijuana-schedule-i-drug-1821426
Colorado’s legal pot is potent, and a little dirty (news-2015) http://www.newschannel10.com/story/28588200/colorados-legal-pot-is-potent-and-a-little-dirty
UCLA Professor Finds Marijuana Is Safer to Smoke Than Tobacco (news-2015) http://www.laweekly.com/music/ucla-professor-finds-marijuana-is-safer-to-smoke-than-tobacco-5658317
The laws on alcohol and marijuana are totally out of sync with the science (news-2015) http://finance.yahoo.com/news/study-confirms-laws-alcohol-marijuana-201029468.html;_ylt=AwrSyCQFpO9UUUMADLjQtDMD
Medical marijuana users could help researchers define risks, benefits (news-2015) https://ca.news.yahoo.com/medical-marijuana-users-could-help-090000965.html
Ladies, you might want to swap the bourbon for a bong (news-2015) http://www.theguardian.com/commentisfree/2015/apr/27/ladies-you-might-want-to-swap-the-bourbon-fora-bong
6 facts about marijuana (news-2015) http://www.pewresearch.org/fact-tank/2015/04/14/6-facts-about-marijuana/
Huge New Review Shows What Medical Marijuana May (and May Not) Help (news-2015) https://www.yahoo.com/health/huge-new-review-shows-what-medical-marijuana-may-122209836947.html
Study confirms safety of cannabis drug CBD (news-2015) https://www.epilepsy.org.uk/news/news/study-confirms-safety-cannabis-drug-cbd-64709
What is the scope of marijuana use in the United States? (news-2015) http://www.drugabuse.gov/publications/research-reports/marijuana/what-scope-marijuana-use-in-unitedstates
The Science Of Decriminalizing Drugs (news-2015) http://www.popsci.com/science-decriminalize-legalize-drugs-marijuana-weed
How the media used one tiny study to wildly exaggerate the threat of marijuana edibles (news-2015) http://www.vox.com/2015/6/22/8826011/pot-edibles-dangerous

CUT, A Guide to the Adulterants, Bulking agents and other Contaminants found in illicit drugs (full-2010) http://www.cph.org.uk/publication/cut-a-guide-to-the-adulterants-bulking-agents-and-other-contaminants-found-in-illicit-drugs/
Contamination – Now we have some real evidence (news–2010) http://ukcia.org/wordpress/?p=296
Medical marijuana tested for toxins and impurities (news-2010) http://www.wmbfnews.com/Global/story.asp?S=12340335
Too many mouldy joints – marijuana and chronic pulmonary aspergillosis (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103256/?tool=pubmed
Fatal alveolar haemorrhage following a “bang” of cannabis (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21943539
Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348083/
Can medical marijuana help rheumatoid arthritis? (news-2012) http://healthyliving.msn.com/diseases/rheumatoid-arthritis/can-medical-marijuana-help-rheumatoid-arthritis-1
Determination of pesticide residues in cannabis smoke (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666265/
Hemoptysis in a young man smoking cannabis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23619207
Medical marijuana users don’t have protections from sub-par pot (news-2013) http://www.katu.com/news/investigators/Medical-marijuana-users-dont-have-protections-from-sub-par-pot-200499471.html
Moldy Marijuana? Legal Markets Spark Push for Health, Safety Standards (news-2013) http://www.cnbc.com/id/100678723
Legalized marijuana states draft laws on purity of pot (news-2013) http://www.dailycamera.com/state-west-news/ci_23690495/legalized-marijuana-states-draft-laws-purity-pot?source=rss
Marijuana Pesticide Contamination Becomes Health Concern As Legalization Spreads (news-2013) http://www.huffingtonpost.com/2013/05/24/marijuana-pesticides-contamination_n_3328122.html
Recurrent myopericarditis as a complication of Marijuana use (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921097/
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24859075
Inhaled medicinal cannabis and the immunocompromised patient (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Determination of Herbicides Paraquat, Glyphosate, and Aminomethylphosphonic Acid in Marijuana Samples by Capillary Electrophoresis (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25413634
Testing of Colorado marijuana for contaminants to begin this year (news-2014) http://gazette.com/testing-of-pot-for-contaminants-to-begin-this-year/article/1536213
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst-2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Colorado’s legal pot is potent, and a little dirty (news-2015) http://www.newschannel10.com/story/28588200/colorados-legal-pot-is-potent-and-a-little-dirty
Marijuana Legalization 2015: EPA Issues Guidance On Marijuana Pesticides Amid Industry Uncertainty (news-2015) http://www.ibtimes.com/marijuana-legalization-2015-epa-issues-guidance-marijuana-pesticides-amidindustry-1959030
Marijuana’s Pesticide Problem (news-2015) http://finance.yahoo.com/news/marijuanas-pesticide-problem-160701940.html;_ylt=AwrXnCduW4JVqwsABr_QtDMD;_ylu=X3oDMTByb2lvbXVuBGNvbG8DZ3ExBHBvcwMxBHZ0aWQDBHNlYwNzcg–

Effects of anandamide on proliferation of and pErk expression in primary hepatic stellate cells of schistosome-induced liver fibrosis mice (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23663762
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24657416

Do patients think cannabis causes schizophrenia? – A qualitative study on the causal beliefs of cannabis using patients with schizophrenia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez
Reasons for illicit drug use in people with schizophrenia: Qualitative study (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999587/?tool=pubmed
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900481/?tool=pubmed
Therapeutical use of the cannabinoids in psychiatry (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055343/?tool=pubmed
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full
Endocannabinoids and Schizophrenia (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3101
Tardive Dystonia and the Use of Cannabis (letter/ forum repost-2010) http://www.420magazine.com/forums/dystonia/169902-tardive-dystonia-use-cannabis.html
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/19785914/abstract/A_behavioural_comparison_of_acute_and_chronic_Delta9_tetrahydrocannabinol_and_cannabidiol_in_C57BL/6JArc_mice_
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19854030
Brain cannabinoid CB2 receptor in schizophrenia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931854
Does intravenous {triangleup}9-tetrahydrocannabinol increase dopamine release? A SPET study (abst–2010)http://www.ncbi.nlm.nih.gov/pubmed?term=20851843
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20660494
Attraction to cannabis among men with schizophrenia: a phenomenological study (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20420097
Alterations in Metabotropic Glutamate Receptor 1a and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia (news – 2010) http://ajp.psychiatryonline.org/article.aspx?articleID=102528&resultClick=1
Oral THC Reduces Aggressive Behavior In Patients With Refractory Psychosis, Study Says (news – 2010) http://www.norml.org/index.cfm?Group_ID=8419
Risk of suicide spurs rimonabant trial to end (news-2010) http://www.thefreelibrary.com/Risk+of+suicide+spurs+rimonabant+trial+to+end.-a0238838571
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice (full–2011) http://www.nature.com/npp/journal/v36/n7/full/npp201134a.html
Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study (full-2011) http://www.ajop.co.za/Journals/November2010/Original%20articles/Cannabis%20use.pdf
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use (full-2011) http://www.hindawi.com/journals/sprt/2011/501726/
Gadolinium-HU-308-incorporated micelles (full – 2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (full-2011) http://jop.sagepub.com/content/26/1/144.long
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabis, COMT and psychotic experiences (full – 2011) http://bjp.rcpsych.org/content/199/5/380.long
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186912/pdf/fnbeh-05-00063.pdf
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives (full – 2011) http://jop.sagepub.com/content/26/1/150.full.pdf+html
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717343/
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
Cannabis with high cannabidiol content is associated with fewer psychotic experiences (full – 2011) http://www.schres-journal.com/article/S0920-9964%2811%2900224-6/fulltext
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21458498
Synthetic cannabinoid JWH-018 and psychosis: An explorative study (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21316162/abstract/Synthetic_cannabinoid_JWH_018_and_psychosis:_An_explorative_study_
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts – 2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21087649
Endocannabinoid system dysfunction in mood and related disorders (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21916860
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21926420
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/20701826/abstract/The_schizophrenia_susceptibility_gene_neuregulin_1_modulates_tolerance_to_the_effects_of_cannabinoids_
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21513772/abstract/Association_between_a_cannabinoid_receptor_gene__CNR1__polymorphism_and_cannabinoid_induced_alterations_of_the_auditory_event_related_P300_potential_
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21430651
Marijuana Use Associated With ‘Superior’ Cognitive Performance In Schizophrenic Patients, Study Says (news-2011) http://www.norml.org/index.cfm?Group_ID=8537
A Brain Wrought Without Omega-3 (news – 2011) http://www.schizophreniaforum.org/new/detail.asp?id=1646
Debunking the Myth of a Link Between Marijuana and Mental Illness (news-2011) http://www.alternet.org/drugs/151776
COMT; another “wrong” result for the reefer madness hype (news-2011) http://ukcia.org/wordpress/?p=924
Synthetic cannabis linked to extended psychosis (news-2011) http://medicalxpress.com/news/2011-05-synthetic-cannabis-linked-psychosis.html
The Link Between Marijuana and Schizophrenia (news – 2011) http://www.time.com/time/health/article/0,8599,2005559,00.html
Why Omega-3s Affect Your Mood (news – 2011) http://voices.yahoo.com/why-omega-3s-affect-mood-8180941.html?cat=5
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459073/
Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong (full-2012) http://easap.asia/journal_file/1201_V22N1_p31.pdf
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/?tool=pubmed
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts (full-2012) http://www.biomedcentral.com/1471-244X/12/112
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full-2012) http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (full – 2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1425/full
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Cortical basket cell dysfunction in schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature (full-2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000600005&lng=en&nrm=iso&tlng=en
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF-2012) http://www.eurekaselect.com/102848/article
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel based morphometric study using DARTEL (abst-2012) http://www.sciencedirect.com/science/article/pii/S0920996412001740
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22687521
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716160
Neurocognitive functioning and cannabis use in schizophrenia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716156
Anandamide dysfunction in prodromal and established psychosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716147
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716155
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice (abst-2012) http://www.springerlink.com/content/ur5784gm34782505/
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22920733
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22831980
‘Cannabis’ receptor discovery may help understanding of obesity and pain (news-2012) http://phys.org/news/2012-08-cannabis-receptor-discovery-obesity-pain.html
Study: Marijuana Linked to Lower Mortality Rate for Patients with Psychotic Disorders (news-2012) http://www.alternet.org/newsandviews/article/936220/study%3A_marijuana_linked_to_lower_mortality_rate_for_patients_with_psychotic_disorders/
Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news-2012) http://www.mhhub.com/archives/16603
Marijuana Compound May Beat Antipsychotics at Treating Schizophrenia (news-2012) http://psychcentral.com/news/2012/06/07/marijuana-compound-may-beat-antipsychotics-at-treating-schizophrenia/39803.html
Marijuana Use Linked to Better Adherence in Psychosis (news-2012) http://www.clinicalpsychiatrynews.com/index.php?id=2407&cHash=071010&tx_ttnews%5Btt_news%5D=138709
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
Cannabis and psychosis: what causes what? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544398/
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033548
An investigation into “two hit” effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice (full – 2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/acps.12108/full
“Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/hup.2312/full
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/
What does a mouse tell us about neuregulin 1-cannabis interactions? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581817/
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst – 2013) http://link.springer.com/article/10.1007/s00213-012-2839-1
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23414608
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21640/abstract
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23670023
Peripheral endocannabinoid system dysregulation in first-episode psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23822951
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663
Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24219803
The role of cannabinoid 1 receptor expressing interneurons in behavior (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24239560
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Cannabidiol as a potential treatment for psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24309088
High K2 use rate among psych unit patients (news – 2013) http://www.odt.co.nz/news/national/262756/high-k2-use-rate-among-psych-unit-patients
GABA deficits disturb endocannabinoid system (news – 2013) http://www.sciencecodex.com/read/gaba_deficits_disturb_endocannabinoid_system-84784
Cannabis psychosis admissions rose after drug reclassified to Class B (news–2013) http://www.guardian.co.uk/science/sifting-the-evidence/2013/jul/18/cannabis-psychosis-uk-drug-class-c
Harvard: Marijuana Doesn’t Cause Schizophrenia (news-2013) http://psychcentral.com/news/2013/12/10/harvard-marijuana-doesnt-cause-schizophrenia/63148.html
Can The Cannabis Component Cannabidiol (CBD) Cure Schizophrenia? (news-2013) http://www.examiner.com/article/can-the-cannabis-component-cannabidiol-cbd-cure-schizophrenia?cid=PROD-redesign-right-next
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full-2014) http://www.ncbi.nlm.nih.gov/pubmed/24518399
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full – 2014) http://jpn.ca/wp-content/uploads/2014/12/39-6-140081.pdf
Cannabinoids and schizophrenia: therapeutic prospects (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
A controlled family study of cannabis users with and without psychosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24309013
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418217
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24457285
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
Genetic predisposition to schizophrenia associated with increased use of cannabis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24957864
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25138234
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25092427
Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use, and Income (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25176118
Cannabis use and suicidal ideations in high-school students (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25253856
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25522381
Risk-taking in schizophrenia and controls with and without cannabis dependence (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467541
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25539511
The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce anti-psychotic effects (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.13000/abstract
Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment? (news – 2014) (requires free registration) http://www.fool.com/investing/general/2014/09/13/is-medical-marijuana-destined-to-become-a-topschi.aspx
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article – 2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page-2015) http://journals.lww.com/psychopharmacology/Citation/2015/02000/Anandamide_Is_Involved_in_Appetite_Related.14.aspx
Cannabis conundrum : Evidence of harm? : Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article-2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25618402
Marijuana Could Be the Answer to Fighting These 3 Diseases (news-2015) (may require free registration) http://www.fool.com/investing/general/2015/01/10/marijuana-could-be-the-answer-to-fighting-these-3.aspx
Impact of Cannabis Use on the Development of Psychotic Disorders (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352721/
Synthetic cannabis-induced mania (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369931/
Cannabis and psychopathology: The meandering journey of the last decade (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462782/
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page-2015) http://journals.lww.com/psychopharmacology/Citation/2015/02000/Anandamide_Is_Involved_in_Appetite
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25363799
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25680767
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25716487
A systematic review of the antipsychotic properties of cannabidiol in humans (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25667194
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders (abst-2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25801289
ssociation of single nucleotide polymorphisms in catechol-O-methyltransferase and serine-threonine protein kinase genes in the Pakistani schizophrenic population: a study with special emphasis on cannabis and smokeless tobacco (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25801838
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25943166
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26071625
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26093170
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Catatonia and Cannabis Withdrawal: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247767
No additive effect of cannabis on cognition in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26235754
Marijuana Could Be the Answer to Fighting These 3 Diseases (news–2015) (may require free registration) http://www.fool.com/investing/general/2015/01/10/marijuana-could-be-the-answer-to-fighting-these-3.aspx
Schizophrenia and weight gain: A new explanation? (news–2015) http://www.alphagalileo.org/ViewItem.aspx?ItemId=149445&CultureCode=en
Cannabinoids may be responsible for weight gain associated with schizophrenia (news–2015) http://medicalxpress.com/news/2015-02-cannabinoids-responsible-weight-gain-schizophrenia.html
Study finds no link between teen marijuana use, mental health issues (news–2015) http://www.foxnews.com/health/2015/08/04/study-finds-no-link-between-teen-marijuana-use-mentalhealth-issues/
Teen marijuana use not linked to later depression, lung cancer, other health problems, study finds (news–2015) http://www.sciencedaily.com/releases/2015/08/150804093718.htm

Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21177293
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22492781
Pathogenesis of Systemic Sclerosis (full-2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full

“Sebocytes’ makeup”: novel mechanisms and concepts in the physiology of the human sebaceous glands (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21384129
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24915599
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full-2014) http://www.jci.org/articles/view/64628

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20561509
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
The endocannabinoid system in sepsis – a potential target to improve microcirculation? (full-2011) http://www.signavitae.com/articles/review-articles/161-the-endocannabinoid-system-in-sepsis-a-potential-target-to-improve-microcirculation
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21279327
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full-2012) http://ccforum.com/content/16/2/R47
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis (full-2012) http://journals.lww.com/anesthesia
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full – 2013) http://www.hindawi.com/journals/mi/2013/741303/
Targeting the Endocannabinoid System to Treat Sepsis (review – 2013) http://www.signavitae.com/articles/review-articles/222-targeting-the-endocannabinoid-system-to-treat-sepsis
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full-2014) http://www.hindawi.com/journals/mi/2014/978678/
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Novel approaches to the development of anti-sepsis drugs (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24697209
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25425209
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full-2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long

Cannabis Salve for Pain- Neuropathy – Yep, I had shingles 😦 (news-2015) http://www.hempista.com/2015/cannabis-salve-pain-neuropathy-shingles/

New Era Dawns on Sickle Cell Pain (full–2010) http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/311
Pain related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids (full-2010) http://bloodjournal.hematologylibrary.org/content/116/3/456.long
Cannibinoids Offer Novel Treatment for Pain in Sickle Cell Disease, Study Suggests (news-2010) http://www.sciencedaily.com/releases/2010/07/100722121225.htm
UM researcher identifies novel treatment for pain in sickle cell disease (news–2010) http://www.eurekalert.org/pub_releases/2010-07/uom-uri072210.php
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779783/
Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502758/
Priapism in a patient with sickle cell trait using marijuana (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24798364
Minnesota’s New Medical Marijuana Law Blocks Research Treating Chronic Sickle Cell Pain (news-2014) http://www.huffingtonpost.com/2014/06/11/minnesota-medical-marijuana_n_5485383.html
Medical marijuana could treat pain caused by sickle cell disease (news-2014) http://www.mndaily.com/news/campus/2014/06/10/medical-marijuana-could-treat-pain-caused-sickle-cell-disease
Vaporized medical marijuana study given green light (news-2014) http://abc7news.com/health/vaporized-medical-marijuana-study-given-green-light/261437/
The Miracle Worker (news-2014) http://ireadculture.com/article-3695-the-father-of-modern-medical-cannabis-research-returns-with-an-allbut-impossible-new-study-of-cannabis-on-humans.html
The Science Behind Sanjay Gupta’s WEED 3 (news-2015) http://blog.sfgate.com/smellthetruth/2015/04/21/the-science-behind-sanjay-guptas-weed-3/

Circulating endocannainoids and N-acyl-ethanolamides in patients with sleep apnea – specific role of oleoylethanolamide (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20429051
A study on the endogenous cannabinoid system synthetic and catabolic enzyme levels in patients with obstructive sleep apnea (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21729625
Treat sleep apnea with medical marijuana (news – 2011) http://www.examiner.com/holistic-health-in-boulder/treat-sleep-apnea-with-medical-marajuana
Circulating anandamide and blood pressure in patients with obstructive sleep apnea (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23032139
Can cannabinoid drug used for nausea in chemotherapy relieve sleep apnea? (news – 2012) http://medicalxpress.com/news/2012-06-cannabinoid-drug-nausea-chemotherapy-relieve.html
Proof of concept trial of dronabinol in obstructive sleep apnea (full-2013) http://www.frontiersin.org/Sleep_Disorders/10.3389/fpsyt.2013.00001/full
Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24121138
Science/Human: THC reduces sleep apnoea in small clinical study (news-2013) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=392
5 Ways Marijuana Affects Your Sleep (news-2013) http://www.leafscience.com/2013/11/25/5-ways-marijuana-affects-sleep/
Identification of a Pharmacological Target for Genioglossus Reactivation throughout Sleep (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902869/
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869068/
Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0111412
Cannabinoid Type 1 Receptor Antagonist, AM251, Prevents Attenuation Of Serotonininduced Apneas By Dronabinol In Sprague-Dawley Rats (abst-2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3901

Trypanocidal Effect of Cannabis sativa on Experimental Camel Trypansomosis (full-2012) http://scialert.net/fulltext/?doi=rjmp.2012.281.285&org=10

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Endocannabinoid signalling: has it got rhythm? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/?tool=pubmed
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial (full-2010) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2010/02000/The_Effects_of_Nabilone_on_Sleep_in_Fibromyalgia_.56.aspx
Sleep and Medicinal Cannabis (abst–2010) http://www.cmcr.ucsd.edu/index.php?option=com_content&view=article&id=151:sleep-and-medicinal-cannabis&catid=41:research-studies&Itemid=135
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20100574
Dreams, endocannabinoids and itinerant dynamics in neural networks: re elaborating Crick-Mitchison unlearning hypothesis (abst–2010) http://adsabs.harvard.edu/abs/2002cond.mat..8590K
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20056119
Study: Smoking pot may ease chronic pain (news – 2010) http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/
Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136458/?tool=pubmed
A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats (full–2011) http://www.hindawi.com/journals/sd/2011/178469/
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) http://annonc.oxfordjournals.org/content/22/9/2086.long
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21867717
Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21262236
Medical marijuana turns former soldier’s life around (news-2011) http://www.examiner.com/cannabis-culture-in-phoenix/medical-marijuana-turns-former-soldier-s-life-around
CADTH Rapid Response Report: Cannabinoids for the treatment of post-traumatic stress disorder (full-2012) http://www.cadth.ca/media/pdf/htis/july-2012/RC0368%20Cannabinoids%20Final.pdf
Cannabidiol in humans-the quest for therapeutic targets (full – 2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Oleamide restores sleep in adult rats that were subjected to maternal separation (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22975223
A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003) (abst – 2012) http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S38.003?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&resourcetype=HWCIT
Neuromodulators for pain management in rheumatoid arthritis (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Marijuana Helps Ease MS Symptoms, Study Finds (news – 2012) http://www.healthline.com/health-blogs/study-roundup/marijuana-multiple-sclerosis-101112
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23343597
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23584096
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23603032
Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking CB1 cannabinoid receptors (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/926.1?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23238438
Sleep Quality Moderates the Relation between Depression Symptoms and Problematic Cannabis Use among Medical Cannabis Users (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23721537
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23952899
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343597
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24412475
The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt (abst–2013) http://www.sciencedirect.com/science/article/pii/S030646031300172X
Federal Government Reports Marijuana Effective in Combatting Certain Cancers Reports ADSI (news–2013) http://www.reuters.com/article/2013/03/12/idUSnGNXUXIPEa+1fe+GNW20130312
Medical marijuana helps senior sleep, contend with other problems of aging (news–2013) http://www.ottawacitizen.com/health/seniors/Medical+marijuana+helps+senior+sleep+contend+with+other/8439474/story.html
Poor Sleep Quality Makes It Harder To Quit Marijuana – Here’s Why (news-2013) http://www.leafscience.com/2013/09/27/poor-sleep-quality-makes-harder-quit-marijuana-why/
Medical Marajuana: Consortium of Multiple Sclerosis Centers (news-2013) http://www.msviews.org/msviewsandnews4/index.php/2012-05-28-00-15-54/2012-07-04-00-19-28/610-medical-marajuana-consortium-of-multiple-sclerosis-centers
Too little sleep may trigger the ‘munchies’ by raising levels of an appetite-controlling molecule (news-2013) http://www.sciencecodex.com/too_little_sleep_may_trigger_the_munchies_by_raising_levels_of_an_appetitecontrolling_molecule-114190
5 Ways Marijuana Affects Your Sleep (news – 2013) http://www.leafscience.com/2013/11/25/5-ways-marijuana-affects-sleep/
Smoking Pot Eases Tremors in Parkinson’s (news – 2013) http://www.medpagetoday.com/MeetingCoverage/MDS/39933
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919802/
Multiple sleep alterations in mice lacking cannabinoid type 1 receptors. (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089432
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869068/
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
Therapeutic benefits of cannabis: a patient survey (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508153
Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24800644
Potential effects of cannabidiol as a wake-promoting agent (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24851090
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24845114
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24987795
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24996194
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
When time stands still: an integrative review on the role of chronodisruption in posttraumatic stress disorder. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25023884
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25356522
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25504799
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25467221
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25467221
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (full-2015) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900413-2/fulltext
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
The effects of chronic marijuana use on circadian entrainment. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25801606
Cannabis withdrawal and sleep: A systematic review of human studies. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25893849
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Rhythmic control of endocannabinoids in the rat pineal gland. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26061461
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst-2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Rhythmic control of endocannabinoids in the rat pineal gland (abst-2015) http://informahealthcare.com/doi/abs/10.3109/07420528.2015.1041596
Marijuana use ups daytime sleepiness among kids (news–2015) http://www.newkerala.com/news/2015/fullnews-19303.html
Can Medical Marijuana Treat Multiple Sclerosis? (news–2015) http://www.webmd.com/multiple-sclerosis/features/medical-marijuana-multiplesclerosis?src=RSS_PUBLIC

Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
Genome-wide association study of antibody response to smallpox vaccine (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367131/
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full-2015) http://www.hindawi.com/journals/mi/2015/349176/

The endocannabinoid 2-arachidonoyl-glycerol controls odor sensitivity in larvae of Xenopus laevis (full–2010) http://www.jneurosci.org/content/30/26/8965.long
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20875432
Endocannabinoid modulation in the olfactory epithelium (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20865377
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) http://annonc.oxfordjournals.org/content/early/2011/02/11/annonc.mdq727.full
Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids—Cannabinoids and Acute Stress Modulate GABA Release (full–2011) http://www.hindawi.com/journals/ijcb/2011/529851/
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397690/
Drug Raids Based on “Smelling” Marijuana (news-2011) http://www.opposingviews.com/i/society/crime/drug-raids-based-smelling-marijuana
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb. (full– 2012) http://www.jneurosci.org/content/32/25/8475.long
G-Protein-Coupled Receptors in Intestinal Chemosensation (full – 2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23453134
In 1981 STASH cologne for men attracted women as well as police and their dogs (news – 2013) http://www.anorak.co.uk/369898/strange-but-true/in-1981-stash-cologne-for-men-attracted-women-as-well-as-police-and-their-dogs.html/
The Truth About Marijuana Smoke: A Smelly Study (news/ad–2013) http://www.airfilters.com/blog/the-truth-about-marijuana-smoke-a-smelly-study/
Identification of odorant-receptor interactions by global mapping of the human odorome (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093037
Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System (link to PDF–2014) http://www.mdpi.com/1424-8220/14/7/13256
The endocannabinoid system controls food intake via olfactory processes (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24509429
Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy volunteers (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24802974
New insights on food intake control by olfactory processes: the emerging role of the endocannabinoid system (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25261796
Mechanism elucidated: How smell perception influences food intake (news–2014) http://www.sciencedaily.com/releases/2014/02/140210114550.htm
The brain mechanism connecting the sense of smell with appetite is discovered (news–2014) http://www.alphagalileo.org/ViewItem.aspx?ItemId=138885&CultureCode=en
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26037800
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26162535
Well, can you still smell that smell? (news–2015) http://www.aspendailynews.com/section/home/167350
Ruling: Smell of marijuana can’t be only basis for searches (news–2015) http://www.tucsonnewsnow.com/story/29609893/ruling-smell-of-marijuana-cant-be-only-basis-forsearches

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma (article – 2010) http://www.canadianjournalofophthalmology.ca/article/S0008-4182%2810%2980129-2/abstract
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=309
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=316
Cannabis Inhalation Associated With Spontaneous Tumor Regression (news – 2010) http://blog.norml.org/2011/03/22/cannabis-inhalation-associated-with-spontaneous-tumor-regression-study-says/
Study: Smoking pot may ease chronic pain (news – 2010) http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/
Smoking cannabis relieves chronic pain (news – 2010) http://www.independent.co.uk/life-style/health-and-families/smoking-cannabis-relieves-chronic-pain-2067287.html
Smoked cannabis reduces chronic pain (news – 2010) http://phys.org/news202360294.html
Marijuana better than pharmaceuticals at treating chronic pain, improving mood (news – 2010)  ttp://www.naturalnews.com/029662_marijuana_chronic_pain.html
Marijuana Smoking Associated with 66% Decrease in Diabetes Risk (news – 2010) http://www.internalmedicinenews.com/index.php?id=495&cHash=071010&tx_ttnews[tt_news]=18557
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation (full – 2011) http://cannabisclinicians.org/wp-content/uploads/2011/12/Cannabis-Inhalation-and-Brain-Tumor-Regression-2011.pdf
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study (abst – 2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=481
Inhaled Cannabis May Keep Brain Cancer in Remission (news – 2011) http://www.freedomisgreen.com/inhaled-marijuana-may-keep-brain-cancer-in-remission/
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full – 2012) http://www.cmaj.ca/content/184/10/1143.long
Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1002/acr.21732/full
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23159379
Use of cannabis among 139 cluster headache sufferers (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23197349
Smoked Cannabis Reduces Some Symptoms of Multiple Sclerosis (news – 2012) http://health.ucsd.edu/news/releases/Pages/2012-05-14-smoked-cannabis-reduces-symptoms-of-multiple-sclerosis.aspx
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults (full – 2013) http://www.amjmed.com/article/S0002-9343%2813%2900200-3/fulltext
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis (full – 2013) http://cid.oxfordjournals.org/content/early/2013/07/03/cid.cit378.long
Cannabis and other illicit drug use in epilepsy patients (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/ene.12081/full
Towards a better Cannabis drug. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005175.pub3/full
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full – 2013) http://www.jleukbio.org/content/92/5/1093.full
Medical Marijuana Coverage Still Lost in the Legal Weeds (article – 2013) http://www.managedcaremag.com/linkout/2013/1/23
Medicinal Cannabis and Painful Sensory Neuropathy (editorial – 2013) http://virtualmentor.ama-assn.org/2013/05/oped1-1305.html
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23609132
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23648372
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
Study claims marijuana tied to lower bladder cancer risk (news – 2013) http://www.usatoday.com/story/news/nation/2013/05/11/study-claims-marijuana-tied-to-lower-bladder-cancer-risk/2153019/
Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection (news – 2013) http://www.aidsmap.com/Smoking-cannabis-does-not-accelerate-progression-of-liver-disease-in-people-with-HIVHCV-co-infection/page/2707524/
Smoking Pot Eases Tremors in Parkinson’s (news–2013) http://www.medpagetoday.com/MeetingCoverage/MDS/39933
The Truth About Marijuana Smoke: A Smelly Study (news/ad–2013) http://www.airfilters.com/blog/the-truth-about-marijuana-smoke-a-smelly-study/
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014)http://www.cfp.ca/content/60/12/1083.long
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0108282
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24614667
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst – 2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst–2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25052875
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25135301
Inhaled medicinal cannabis and the immunocompromised patient (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Effect of Marijuana Use on Outcomes in Traumatic Brain Injury (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25264643
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25282526
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst–2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901929-2/abstract?cc=y
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25533893
Pot Smokers Show Less Inflammation (news – 2014) http://news.yahoo.com/pot-smokers-show-less-inflammation-150518763.html
Marijuana use associated with lower death rates in patients with traumatic brain injuries (news – 2014) http://www.eurekalert.org/pub_releases/2014-10/labr-mua100214.php
Marijuana In A Pill? Why Patients Might Be Better Off Smoking It (news – 2014) http://www.leafscience.com/2014/01/19/marijuana-pill-patients-might-better-smoking/
Marijuana may slow spread of HIV (news – 2014) http://www.upi.com/blog/2014/02/19/Marijuana-may-slow-spread-of-HIV/4561392843139/
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25623697
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (abst-2015) http://www.sciencedirect.com/science/article/pii/S0885392414003121
How Medical Marijuana’s Chemicals May Protect Cells (news-2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full-2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25623697
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (abst-2015) http://www.sciencedirect.com/science/article/pii/S0885392414003121
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25716487
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588
Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25978795
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26152606
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26187456
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26257969
Substance abuse risk not greater in those using medical marijuana with prescribed opioids (news-2015) http://www.eurekalert.org/pub_releases/2015-05/joso-sar051115.php
How Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/

Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France (full–2010) http://eurpub.oxfordjournals.org/content/20/2/157.long

Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full–2010) http://molpharm.aspetjournals.org/content/78/2/260.long
Cannabis and crime: findings from a longitudinal study (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19839964/full_citation/Cannabis_and_crime:_findings_from_a_longitudinal_study_
A Life-course Perspective on the “Gateway Hypothesis” (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20943588
Gender moderates the impact of stereotype threat on cognitive function in cannabis users (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20483199
Are Stoners Really Dumb, or Do They Just Think They Are? (news-2010) http://healthland.time.com/2010/11/18/are-stoners-really-dumb-or-do-they-just-think-they-are/
Gender differences in adolescent marijuana use and associated psychosocial characteristics (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359836/
Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among Southeast Asian Adolescents and Emerging Adults (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193281/?tool=pubmed
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186916/
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
The social contagion effect of marijuana use among adolescents (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018468/?tool=pubmed
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258364/
The association between early conduct problems and early marijuana use in college students (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163297/
Profile of Psychoactive Substances Consumption in Workplace (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21635864
Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young adulthood (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21733007
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21926420
Oregon’s workplaces safest ever, despite 40,000 medical marijuana patients (news–2011) http://www.examiner.com/article/oregon-s-workplaces-safest-ever-despite-40-000-medical-marijuana-patients
The Kids Are All Right, Even if Their Parents Grow Pot (news–2011) http://www.parentdish.com/2011/07/27/the-kids-are-all-right-even-if-their-parents-grow-pot/
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission (full-2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033260
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664416/
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389197/
The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22682099
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23002698
‘It’s just a social thing’: Drug use, friendship and borderwork among marginalized young people (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23352335
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22495620
Cannabinoid 2 receptors regulate impulsive behavior (news–2012) http://medicalxpress.com/news/2012-03-cannabinoid-receptors-impulsive-behavior.html
Does Cannabis Boost Creativity? (news-2012) http://www.wakingtimes.com/2012/03/14/does-cannabis-boost-creativity/
Cannabis and Creativity (news–2012) https://www.psychologytoday.com/blog/psychology-masala/201204/cannabis-and-creativity
The Science Behind Cannabis and Creativity (news–2012) http://www.neboagency.com/blog/the-science-behind-cannabis-and-creativity/
Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
From “Social Supply” to “Real Dealing”: Drift, Friendship, and Trust in Drug-Dealing Careers (full–2013) http://jod.sagepub.com/content/43/4/392.full.pdf+html
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855086/
Perception of tobacco, cannabis, and alcohol use of others is associated with one’s own use (full–2013) http://www.ascpjournal.org/content/8/1/15
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Higher rates of adolescent substance use in child welfare versus community populations in the United States (link to PDF- 2013) http://www.jsad.com/jsad/article/Higher_Rates_of_Adolescent_Substance_Use_in_Child_Welfare_Versus_Community_/4863.html
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
Illegal drugs and delinquency (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23434380
The role of child protection in cannabis grow-operations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23453301
CB1 receptor signaling regulates social anxiety and memory (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23647582
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24261614
Can Marijuana Reduce Social Pain? (abst – 2013) http://spp.sagepub.com/content/early/2013/05/13/1948550613488949.abstract
Cannabis Use, Employment, and Income: Fixed-Effects Analysis of Panel Data (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23793384
CB1 cannabinoid receptor-mediated aggressive behavior (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23916480
Cannabis use motives and personality risk factors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24368004
This bud’s for you: Marijuana identified as a buffer against loneliness, study suggests (news–2013) http://o.canada.com/life/marijuana-can-act-as-buffer-against-loneliness-study-suggests/
Use of Marijuana, Inhalants Higher in Teens in Child Welfare System: Study (news–2013) http://www.drugfree.org/join-together/drugs/use-of-marijuana-inhalants-higher-in-teens-in-child-welfare-system-study
Marijuana Unlikely To Cause Violence, Study Finds (news–2013) http://www.leafscience.com/2014/01/10/marijuana-unlikely-cause-violence-study-finds/
Marijuana Use In Prisons: Why The Swiss Think It’s Safe And Positive (news–2013) http://www.medicaldaily.com/could-marijuana-use-lead-calmer-prison-environment-swiss-prisons-finddrugs-effects-inmates-positive
The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006 (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0092816
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093771
Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125187/
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2014.962716#tabModule
Marijuana Policy in Colorado (full – 2014) http://object.cato.org/sites/cato.org/files/pubs/pdf/working-paper-24_2.pdf
Early onset of cannabis use: Does personality modify the relation with changes in perceived parental involvement? (full–2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901893-6/fulltext
Acute alcohol use temporally increases the odds of male perpetrated dating violence: A 90-day diary analysis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858531/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full – 2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html
Couples’ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25134048
Interpersonal Guilt and Substance Use in College Students. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24579980
Strain and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Socialization Instances Linked to Cannabis Experimentation Among French Teenagers (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25099311
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
Frequent electronic media communication with friends is associated with higher adolescent substance use (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
Risk-taking in schizophrenia and controls with and without cannabis dependence (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467541
Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25547462
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice (abst-2014)
Marijuana Smokers Are Moral And Selfless In Romantic Relationships, Survey Suggests (news–2014) http://www.ibtimes.com/marijuana-smokers-are-moral-selfless-romantic-relationships-survey-suggests-1639310
Marijuana Use Results in Less Domestic Violence (news–2014) http://blog.sfgate.com/smellthetruth/2014/08/19/marijuana-in-marriage-equals-less-violence-study-finds/
10 percent of Americans admit to illicit drug use (news–2014) http://www.myfoxmaine.com/story/26450180/10-percent-of-americans-admit-to-illicit-drug-use
After California decriminalized marijuana, teen arrest, overdose and dropout rates fell (news–2014) http://www.washingtonpost.com/blogs/wonkblog/wp/2014/10/15/after-california-decriminalized-weedteen-arrest-overdose-and-dropout-rates-fell/
Pot Is the New Normal (news – 2014) http://time.com/3514137/marijuana-legalization-colorado-new-normal/
Harvard Potheads: Then and Now (news – 2014) http://www.thecrimson.com/article/2014/9/12/harvard-potheads-then-andnow/?utm_source=thecrimson&utm_medium=web_primary&utm_campaign=recommend_sidebar
Cato Paper Highlights Marijuana Legalization’s Ho-Hum Impact in Colorado (news – 2014) http://reason.com/blog/2014/10/27/cato-paper-highlights-marijuana-legaliza
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Young adult cannabis users report greater propensity for risk-taking only in nonmonetary domains (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0376871614020006
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25832823
Role of CB2 receptors in social and aggressive behavior in male mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25921034
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
From substance use to homelessness or vice versa? (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25989002
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26115351
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Pediatrician decides: alcohol or marijuana (news – 2015) http://blog.sfgate.com/smellthetruth/2015/03/16/pediatrician-decides-alcohol-or-marijuana/
An open letter to those who wear cannabis clothes (news – 2015) http://www.pickandmixseeds.co.uk/blogs/cannabis-news/17913624-an-open-letter-to-those-who-wearcannabis-clothes
An Open Letter to Those Who Oppose Cannabis Clothes (news – 2015) http://www.ladybud.com/2015/05/19/an-open-letter-to-those-who-oppose-cannabis-clothes/
Getting high in senior year: NYU study examines reasons for smoking pot (news – 2015) http://www.eurekalert.org/pub_releases/2015-06/nyu-ghi062915.php
Retired Cop: I Never Encountered A Person ‘Acting Out Under The Influence Of Marijuana’ (news – 2015) http://www.huffingtonpost.com/2015/05/12/texas-marijuana-ad_n_7261626.html

New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (abst – 2010) http://msj.sagepub.com/cgi/content/abstract/16/6/707?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
Role of cannabinoids in the treatment of pain and (painful) spasticity (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21142261
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst – 2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to PDF – 2011) http://www.dovepress.com/articles.php?article_id=7675
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis (abst – 2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
Cannabinoids in children (abst – 2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols) (full – 2012) http://msj.sagepub.com/content/18/2/219.long
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full – 2012) http://www.cmaj.ca/content/184/10/1143.long
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
What place for cannabis extract in MS? (abst – 2012) http://dtb.bmj.com/content/50/12/141.abstract
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23072659
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861?dopt=Abstract
Smoked Cannabis Reduces Some Symptoms of Multiple Sclerosis (news – 2012) http://health.ucsd.edu/news/releases/Pages/2012-05-14-smoked-cannabis-reduces-symptoms-of-multiple-sclerosis.aspx
Cannabis as Painkiller (news – 2012) http://www.sciencedaily.com/releases/2012/08/120807101232.htm
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full – 2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/22726074
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23625705
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24121462
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full – 2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full – 2014) http://www.karger.com/Article/FullText/357742
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis related spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25278116
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467189
“Disease Modifying Nutricals” for multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25435020
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ane.12287/full
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26103030
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26103031
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists (abst–2015)
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cannabinoids for the Treatment of Movement Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206230
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis (abst–2015) http://informahealthcare.com/doi/abs/10.1586/14737175.2015.1067607
Huge New Review Shows What Medical Marijuana May (and May Not) Help (news–2015)
Can Medical Marijuana Treat Multiple Sclerosis? (news–2015) http://www.webmd.com/multiple-sclerosis/features/medical-marijuana-multiplesclerosis?src=RSS_PUBLIC

Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826109/?tool=pubmed
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20156559
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20434606
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst – 2011) http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/lb422?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21265596/abstract/Spinal_Cord_Injuries_Induce_Changes_of_CB1_Cannabinoid_Receptor_and_C_C_Chemokine_Expression_in_Brain_Areas_Underlying_Circuitry_of_Chronic_Pain_Conditions_
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21915768
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265030/?tool=pubmed
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst – 2012) http://www.biomedexperts.com/Abstract.bme/22791629/A_cell_population_that_strongly_expresses_the_CB1_cannabinoid_receptor_in_the_ependyma_of_the_rat_spinal_cord
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426389
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http://www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http://www.jneuroinflammation.com/content/10/1/91
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2013) http://www.sciencedirect.com/science/article/pii/S0306452213007835
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF – 2013) http://www.eurekaselect.com/107976/article
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23981015
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979158/
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full–2014) http://www.sciencedirect.com/science/article/pii/S0306452213010531
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0113161
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Cannabinoids to treat spinal cord injury (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25805333
CB 1Cannabinoid Receptor Agonist Inhibits Matrix Metalloproteinase Activity in Spinal Cord Injury: A Possible Mechanism of Improved Recovery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25881484
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231

Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145934/
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23808969

Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/7/34_7_1090/_pdf
Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182059/
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full–2013) http://www.jleukbio.org/content/92/5/1093.full
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067587
Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687668/
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice (full–2013) http://atvb.ahajournals.org/content/33/2/215.long
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23508466
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25497453
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full-2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/

Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20872894
High-performance sport, marijuana, and cannabimimetics (full-2011) http://jat.oxfordjournals.org/content/35/9/624.long
Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22872465
Broncos Linebacker Failed Two Drug Tests By Providing ‘Non-Human Urine’ (news-2012) http://www.thepostgame.com/blog/dish/201207/broncos-linebacker-failed-two-drug-tests-providing-non-human-urine
Why should Cannabis be Considered Doping in Sports? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654312/
Athletes and Pot: Legalized marijuana in a league of its own (news-2013) http://www.denverpost.com/sports/ci_24809768/athletes-and-pot-legalized-marijuana-league-its-own?source=rss
UFC Raises Marijuana Testing Threshold (news–2013) http://www.theweedblog.com/ufc-raises-marijuana-testing-threshold/
Hair-based rapid analyses for multiple drugs in forensics and doping: application of dynamic multiple reaction monitoring with LC-MS/MS (full-2014) http://journal.chemistrycentral.com/content/8/1/73
UPLC-ESI-Q-TOF-MSE identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24742771
Marijuana Bowl: Leading Up To Football’s Biggest Game, The NFL May Want to Consider Legalizing Weed As Way To Treat Concussions (news-2014) http://www.medicaldaily.com/marijuana-bowl-leading-footballs-biggest-game-nfl-may-want-consider-legalizing-weed-way-treat-267570
CHART: College Lacrosse Athletes Are More Likely To Use Marijuana Than Any Other Sport (news–2014)http://finance.yahoo.com/news/chart-college-lacrosse-athletes-more-170509114.html;_ylt=AwrTWfyJpdJTKAsAdCjQtDMD
Annual banned-substance review: analytical approaches in human sports drug testing (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/dta.1769/full
Marijuana’s Surprising Effects On Athletic Performance (news–2015) http://finance.yahoo.com/news/marijuanas-surprising-effects-athletic-performance-183230768.html;_ylt=AwrTWVV1Z8BUa1EAyA_QtDMD
Is it time to legalize marijuana in sports? (news–2015) http://www.sandiegouniontribune.com/news/2015/aug/01/marijuana-sports-opioids-arguments-kyle-turley/
Schools employ many different ways to test for drugs (news–2015) http://www.abqjournal.com/625738/sports/schools-employ-many-different-ways-to-test-for-drugs.html

Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975171/?tool=pubmed
Pleiotropic effects of prostaglandin E(2) in hematopoiesis; prostaglandin E(2) and other eicosanoids regulate hematopoietic stem and progenitor cell function (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21722751
Scientists Meet to Discuss Cannabinoids and Stem Cells (news – 2011) http://www.examiner.com/medical-marijuana-in-philadelphia/scientists-meet-to-discuss-cannabinoids-and-stem-cells#ixzz1RmgEd9oq
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
G protein-coupled receptor crosstalk and signaling in hematopoietic stem and progenitor cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22901257
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immunosuppressive Properties (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842278/
The effect cannabichromene on adult neural stem/progenitor cells. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23941747
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076098
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system (abst-2013) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23231/abstract
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936357/
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart. (link to PDF–2014) http://life.scichina.com:8082/sciCe/EN/abstract/abstract513395.shtml#
Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells (full-2015) http://www.hindawi.com/journals/bmri/2015/874982/
Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells (full-2015) http://www.hindawi.com/journals/bmri/2015/874982/
A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428713/
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways. (full – 2015) http://link.springer.com/article/10.1007/s11481-015-9609-x/fulltext.html
Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via PGE2 and P-selectin Activity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25931248
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26114153

Science/Human: Cannabis effective in a patient with stiff person syndrome (news-2012) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=376
Stiff Person Syndrome (news-2012) (needs registration) http://www.inspire.com/groups/rare-disease/discussion/stiff-person-syndrome-18/
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/22726074
Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019963/

Endogenous cannabinoid signaling is essential for stress adaptation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889099/?tool=pmcentrez
Motion Sickness, Stress and the Endocannabinoid System (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?tool=pmcentrez
Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of Endocannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full – 2010) http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878
Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress (full – 2010) http://www.nature.com/npp/journal/v35/n11/full/npp201099a.html
Receptors triggered by pot may lessen hit from chronic stress (news–2010) http://arstechnica.com/science/2010/05/brains-endogenous-cannabinoids-lessen-impact-of-stress/
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress (full – 2011) http://www.sciencedirect.com/science/article/pii/S0091305711002310
Endocannabinoids and the cardiovascular response to stress (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21708837
Effects of exercise stress on the endocannabinoid system in humans under field conditions (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22101870
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21600961
New Findings on How the Brain’s Own Marijuana-Like Chemicals Suppress Pain (news – 2011) http://www.alphagalileo.org/ViewItem.aspx?ItemId=113538&CultureCode=en
Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652685/
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice (full – 2012) http://eurheartj.oxfordjournals.org/content/33/24/3124.full
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549323/
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442338/
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response (abst – 2012) http://www.journaldatabase.org/articles/bidirectional_regulation.html
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22734681
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22777139
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http://content.karger.com/produktedb/produkte.asp?doi=339113
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23237313
Cannabinoid Modulation of Midbrain Urocortin 1 Neurones During Acute and Chronic Stress (abst – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2012.02355.x/abstract
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full – 2013) http://www.biolmoodanxietydisord.com/content/3/1/19
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682147/
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883309/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23298518
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23433741
Distress, Coping, and Drug Law Enforcement in a Series of Patients Using Medical Cannabis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23538974
Emotional, endocrine and brain anandamide response to social challenge in infant male rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23660109
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23743650
Cannabinoids and glucocorticoids modulate emotional memory after stress (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23954749
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24035186
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24037493
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24141570
Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24316201
Amygdala FAAH and anandamide: mediating protection and recovery from stress (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24325918
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24367128
Why resolutions about taking up physical activity are hard to keep (news-2013) http://www.thefreelibrary.com/Why+resolutions+about+taking+up+physical+activity+are+hard+to+keep.-a0313904638
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full-2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html
A role for endocannabinoids in acute stress-induced suppression of the hypothalamic pituitary-gonadal axis in male rats (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913894/
Effects of chaiyuwendan decoction on endocannabinoids levels in adipose tissue of rats with chronic stress-induced depression (full – 2014) http://www.journaltcm.com/modules/Journal/contents/stories/141/16.pdf
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full – 2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
Cannabis use and anxiety: is stress the missing piece of the puzzle? (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241884/
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24467609
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12716/abstract
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Endocannabinoids and energy homeostasis: An update (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24752980
Cannabinoids and schizophrenia: therapeutic prospects (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24861565
Stress regulates endocannabinoid-CB1 receptor signaling (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24882055
Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload (abst – 2014) http://www.freedomwares.ca/p80cannabinoid-receptor-cb2-prevents-development-heart-failure-murine_model-pressure-overload/
Cannabinoids, endocannabinoids and stress (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch5/summary
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25048388
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (abst – 2014) http://www.cell.com/neuron/abstract/S0896-6273%2814%2900017-8
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25111814
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25106694
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25083571
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25100669
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25221540
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25263804
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25488672
Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress induced relapse in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25522382
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25548107
Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25547713
Marijuana’s anxiety relief effects: Receptors found in emotional hub of brain (news – 2014) http://www.sciencedaily.com/releases/2014/03/140306142803.htm
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full-2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25572435
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25581607
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25618404
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25641667
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress (abst – 2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23539/abstract
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25754825
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25656689
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25740517
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25707713
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25701682
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25827923
Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress (abst – 2015)
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (abst – 2015)
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25988529
Neurobiological Interactions Between Stress and the Endocannabinoid System (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26068727
Evidence against a critical role of CB1 receptors in adaptation of the hypothalamicpituitary-adrenal axis and other consequences of daily repeated stress (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26092203
Stress-related synaptic plasticity in the hypothalamus (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26087679
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Marijuana Is Effective In Treating Depression – Latest Study (news-2015) http://au.ibtimes.com/marijuana-effective-treating-depression-latest-study-1419071
Research Has Revealed Good News About Marijuana’s Effect on Mental Health (news – 2015) http://www.attn.com/stories/855/marijuana-depression-research-mental-health

Keep Your Marijuana Fresh With This Long-Term Storage Option (news-2012) http://www.weedist.com/2012/07/keep-your-marijuana-fresh-with-this-long-term-storage-option/
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment (full – 2010) http://www.fasebj.org/content/24/3/788.long
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia (full-2010) http://stroke.ahajournals.org/content/41/12/2956.long
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke (link to PDF – 2010) http://www.mdpi.com/1424-8247/3/7/2197
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20875047
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic ischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19900555/abstract/The_neuroprotective_effect_of_cannabidiol_in_an_in_vitro_model_of_newborn_hypoxic_ischemic_brain_damage_in_mice_is_mediated_by_CB_2__and_adenosine_receptors_
Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21470162/abstract/Targeting_the_Endocannabinod_System_to_Limit_Myocardial_and_Cerebral_Ischemic_and_Reperfusion_Injury_
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21443454
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia ischemia in newborn pigs (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21654550
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311
Medical cannabis: the opportunity versus the temptation (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?tool=pubmed
Update on the role of cannabinoid receptors after ischemic stroke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?tool=pubmed
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection (full-2012) http://stroke.ahajournals.org/content/43/1/211.long
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446851/
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion (full – 2012) http://www.jneuroinflammation.com/content/9/1/76
Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22119394
The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia-(abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/21909954
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22678129
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22480617
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23202804
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23202804
“A Marijuana Bud a Day Keeps the Stroke Away” (news-2012) http://www.tokeofthetown.com/2012/04/a_marijuana_bud_a_day_keeps_the_stroke_away.php
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
Is the cardiovascular system a therapeutic target for cannabidiol? (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04351.x/full
Drug-Induced Hypothermia in Stroke Models: Does it Always Protect? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081530/
Does smoking marijuana cause stroke? (article-2013) http://www.thepoisonreview.com/2013/01/26/does-smoking-marijuana-cause-stroke/
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23148948
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst–2013) http://link.springer.com/article/10.1007/s11064-012-0927-6
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23414569
Acupuncture therapy for stroke patients (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24215922
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.4?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window, combination with t-PA and efficacy in aged rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23791950
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
Synthetic Cannabis and Acute Ischemic Stroke (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24119618
Ischemic stroke after use of the synthetic marijuana “spice” (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24212384
Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24323810
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news-2013) http://www.sciencedaily.com/releases/2013/02/130221141140.htm
Cannabinoid Trans-Caryophyllene Protects Brain Cells From Ischemia (news-2013) http://www.medicalnewstoday.com/articles/256799.php
Smoking “spice” associated with stroke in healthy, young adults (news-2013) http://www.medicalnewstoday.com/releases/269132.php
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF-2014) http://www.mdpi.com/1420-3049/19/11/18781
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24721671
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24874648
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25179201
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25241766
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Cannabinoids in experimental stroke: a systematic review and meta-analysis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25492113
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23943518
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture
pretreatment via cannabinoid CB1 receptor in mice. (full – 2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Time-Dependent Protection of CB2 Receptor Agonist in Stroke. (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132487
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemiareperfusion through activating cannabinoid receptor 2 (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26032254
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26215450
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26238742

Marihuana and Stuttering (anecdotal–undated) http://rxmarijuana.com/shared_comments/stuttering.htm
Stuttering, Pain and Battle Fatigue Part 1 (news–2011) http://salem-news.com/articles/february012011/stuttering-pain-pl.php
Stuttering, Pain and Battle Fatigue Part 2 (news–2011) http://salem-news.com/articles/february082011/stuttering-2-plr.php

Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878847/
Suicides in other trials led to early termination of trial into effects of weight loss drug rimonabant on cardiovascular outcomes (CRESCENDO study news – 2010) http://www.eurekalert.org/pub_releases/2010-08/l-sio081110.php
Risk of suicide spurs rimonabant trial to end (news-2010) http://www.thefreelibrary.com/Risk+of+suicide+spurs+rimonabant+trial+to+end.-a0238838571
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21497918
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Suicidal ideation and self-harm following K2 use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23304900
Medical Marijuana May Prevent Suicides, Study Finds (news – 2013) http://www.leafscience.com/2014/01/23/medical-marijuana-may-prevent-suicides-study-finds/
Does the legalization of medical marijuana increase completed suicide? (full–2014) http://informahealthcare.com/doi/full/10.3109/00952990.2014.910520
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full–2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
Medical Marijuana Laws and Suicides by Gender and Age (abst–2014) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301612?journalCode=ajph
Cannabis use and suicidal ideations in high-school students (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Medical Marijuana Cuts Suicide Rates By 10% In Years Following Legalization (news–2014) http://www.medicaldaily.com/medical-marijuana-cuts-suicide-rates-10-years-following-legalization-268472
After California decriminalized marijuana, teen arrest, overdose and dropout rates fell (news–2014) http://www.washingtonpost.com/blogs/wonkblog/wp/2014/10/15/after-california-decriminalized-weed-teen-arrest-overdose-and-dropout-rates-fell/
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26253623